Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045119
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:31
Documents
45
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 563915
2 ex31-1.htm EX-31.1 13538
3 ex31-2.htm EX-31.2 13276
4 ex32-1.htm EX-32.1 8118
5 ex32-2.htm EX-32.2 7834
  Complete submission text file 0001493152-24-045119.txt   3199672

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE afjk-20240930.xsd EX-101.SCH 24083
7 XBRL CALCULATION FILE afjk-20240930_cal.xml EX-101.CAL 23659
8 XBRL DEFINITION FILE afjk-20240930_def.xml EX-101.DEF 119725
9 XBRL LABEL FILE afjk-20240930_lab.xml EX-101.LAB 186154
10 XBRL PRESENTATION FILE afjk-20240930_pre.xml EX-101.PRE 159157
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 462061
Mailing Address 10 EAST 53RD STREET SUITE 3001 NEW YORK NY 10022
Business Address 10 EAST 53RD STREET SUITE 3001 NEW YORK NY 10022 34 678 035200
Aimei Health Technology Co., Ltd. (Filer) CIK: 0001979005 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41880 | Film No.: 241454054
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)